Generic Savella

Scientists at the University of Missouri (USA) conducted a study, which aims – to find out how fibromyalgia affects family relationships. In the experiment, attended by couples in which one of the spouses was suffering from fibromyalgia, and the other was healthy. Couples filled the diaries, which reflected his feelings towards her husband and the problems in family relationships.

The American pharmaceutical company Forest Laboratories announced the acquisition of intellectual property rights to the drug Savella in the United States and Canada, previously owned by Janssen Pharmaceuticals (division of Johnson & Johnson), for 357 million dollars. USA.

Description:

  • Savella– is the drug which has the main active substance- Milnacipran. It is an inhibitor of the reuptake of norepinephrine and serotonin. Fibromyalgia remedy. This drug is designed to treat antidepressant conditions, it acts on serotonin in humans. Norepinephrine, in turn, acts as a treatment for chronic pain. The course of this drug takes 1 month, at least a week is needed to ensure that the drug began to act. This drug is unique in its kind, analogues of milnacipran don’t exist.

Additional information:

  • Milnacipran, which was originally approved in 1980 in Europe for the treatment of depression, was developed as a drug for the treatment of fibromyalgia companies «Forest Laboratories Inc.» and «Cypress Bioscience Inc.» under the brand name Savella ™ and placed on the pharmaceutical market in the US in 2009.

All these products contributed to an increase in market painkillers in the past few years. The expansion of indications for the use of drugs on pain management, will further increase the market painkillers. Annual sales of some of these drugs in developed countries in 2009. (sales of Lyrica and Cymbalta are sales of all approved indications, for the treatment of neuropathic pain and fibromyalgia, these drugs are prescribed in the 30-35 and 20-25%, respectively.)